Skip to main content
ImmuneCited

Beta-Glucan لـ Upper Respiratory Tract Infections

A

Meta-analysis of 13 randomized controlled trials shows yeast beta-glucan may help reduce the incidence, number of episodes, and duration of upper respiratory tract infections compared to placebo. A 16-week RCT with 162 participants found 25% reduction in symptomatic cold infections.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dbeta\u002Dglucan\u0026condition\u003Dupper\u002Drespiratory\u002Dinfections'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

الخلاصة

Meta-analysis of 13 randomized controlled trials shows yeast beta-glucan may help reduce the incidence, number of episodes, and duration of upper respiratory tract infections compared to placebo. A 16-week RCT with 162 participants found 25% reduction in symptomatic cold infections.

Key Study Findings

Randomized Controlled Trial
The anti-infective effect of β-glucans in children.
Dose: 10 mg مقابل: Placebo Outcome: Body weight التأثير: None None

المجتمع المدروس: None

In Vitro
Dry blood spot samples to monitor immune-associated mRNA expression in intervention studies: Impact of Baker's …
Dose: 250 mg/d مقابل: None Outcome: oxidative stress markers التأثير: None None

المجتمع المدروس: None

Randomized Controlled Trial 12 weeks Double-blind
β -Glucan Improves Protective Qi Status in Adults with Protective Qi Deficiency-A Randomized, Placebo-Controlled, and …
Dose: None مقابل: Placebo Outcome: Protective Qi status improvement التأثير: None None

المجتمع المدروس: Adults with Protective Qi deficiency

Meta-Analysis
Effects of yeast β-glucans for the prevention and treatment of upper respiratory tract infection in …
Dose: 95% مقابل: placebo Outcome: None التأثير: OR = 0.345 p < 0.001

المجتمع المدروس: healthy subjects

Randomized Controlled Trial n=69
Soluble and Insoluble Yeast β-Glucan Differentially Affect Upper Respiratory Tract Infection in Marathon Runners: A …
Dose: 250 mL/d مقابل: Placebo Outcome: None التأثير: None None

المجتمع المدروس: URTI patients

Randomized Controlled Trial n=132 Double-blind
Beverage Containing Dispersible Yeast β-Glucan Decreases Cold/Flu Symptomatic Days After Intense Exercise: A Randomized Controlled …
Dose: 250 mL/d مقابل: Placebo Outcome: None التأثير: None p < .05

المجتمع المدروس: URTI patients

Key Statistics

13

الدراسات

2000

المشاركون

Positive

A

التقييم

Referenced Papers

International journal for … 2024 5 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
250-500 mg/day
immunesupport:
250-750 mg/day

الحد الأعلى: No established UL

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
10 mg -- Positive --
250 mg/d -- Positive --
None 12 weeks Positive --
95% -- Positive --
250 mL/d -- Mixed 69
250 mL/d -- Neutral 132
900 mg 16.0 weeks Positive 299
367 mg 12.9 weeks Positive 34

أفضل وقت للتناول: On empty stomach for optimal immune activation

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Generally very well tolerated
  • Mild gastrointestinal effects (bloating)
  • Allergic reactions in yeast-sensitive individuals

التفاعلات المعروفة

  • Immunosuppressant medications (may counteract immunosuppression)
  • Generally few known drug interactions

الحد الأقصى المسموح به: No established UL

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Beta-Glucan help with Upper Respiratory Tract Infections?
Based on 13 studies with 2,000 participants, there is strong evidence from multiple clinical trials that Beta-Glucan may support Upper Respiratory Tract Infections management. Our evidence grade is A (Strong Evidence).
How much Beta-Glucan should I take for Upper Respiratory Tract Infections?
Studies have used various dosages. A commonly studied range is 250-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Beta-Glucan?
Reported side effects may include Generally very well tolerated, Mild gastrointestinal effects (bloating), Allergic reactions in yeast-sensitive individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Beta-Glucan and Upper Respiratory Tract Infections?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 13 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

مكونات أخرى لـ Upper Respiratory Tract Infections

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.